ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
Adjusted price
−52.34% total return, past year
Key statistics
- Market cap
- $29.4B
- P/E (TTM)
- 38.3
- 52-week range
- $205.48$491.22
- Beta (5Y monthly)
- 0.27
- Median dollar volume
- $307M
- Shares outstanding
- 133.8M
- Revenue, last 12 months
- $4.8B
- Sector
- Health Care
- First close
- Jun 1, 2004
Returns
Total
- 1M
- −17.8%
- YTD
- −44.7%
- 1Y
- −52.3%
Per year
- 3Y
- +7.1%
- 5Y
- +2.7%
- 10Y
- +12.5%
- 20Y
- +14.7%
- Since 2004
- +16.7%
Financials
Annual returns
2004 from Jun 1 · 2026 through Oct 2